Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $34.05 million. The enterprise value is $63.88 million.
Important Dates
The last earnings date was Monday, May 19, 2025, after market close.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.37 million shares outstanding. The number of shares has increased by 4.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.37M |
| Shares Change (YoY) | +4.61% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | 44.15% |
| Owned by Institutions (%) | 14.91% |
| Float | 3.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| Forward PS | n/a |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.14 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.09 |
Financial Efficiency
Return on equity (ROE) is -28.56% and return on invested capital (ROIC) is -7.83%.
| Return on Equity (ROE) | -28.56% |
| Return on Assets (ROA) | -5.65% |
| Return on Invested Capital (ROIC) | -7.83% |
| Return on Capital Employed (ROCE) | -16.22% |
| Revenue Per Employee | $236,841 |
| Profits Per Employee | -$105,497 |
| Employee Count | 765 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, Zepp Health has paid $13.73 million in taxes.
| Income Tax | 13.73M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.15% in the last 52 weeks. The beta is 0.84, so Zepp Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -20.15% |
| 50-Day Moving Average | 2.63 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 41.41 |
| Average Volume (20 Days) | 34,841 |
Short Selling Information
| Short Interest | 4,364 |
| Short Previous Month | 4,313 |
| Short % of Shares Out | 0.07% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, Zepp Health had revenue of $181.18 million and -$80.71 million in losses. Loss per share was -$5.00.
| Revenue | 181.18M |
| Gross Profit | 69.90M |
| Operating Income | -49.72M |
| Pretax Income | -23.90M |
| Net Income | -80.71M |
| EBITDA | -45.37M |
| EBIT | -49.72M |
| Loss Per Share | -$5.00 |
Full Income StatementBalance Sheet
The company has $77.43 million in cash and $107.26 million in debt, giving a net cash position of -$29.83 million or -$2.08 per share.
| Cash & Cash Equivalents | 77.43M |
| Total Debt | 107.26M |
| Net Cash | -29.83M |
| Net Cash Per Share | -$2.08 |
| Equity (Book Value) | 232.04M |
| Book Value Per Share | 16.15 |
| Working Capital | 30.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 38.58%, with operating and profit margins of -27.44% and -44.54%.
| Gross Margin | 38.58% |
| Operating Margin | -27.44% |
| Pretax Margin | -36.99% |
| Profit Margin | -44.54% |
| EBITDA Margin | -25.04% |
| EBIT Margin | -27.44% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.61% |
| Shareholder Yield | -4.61% |
| Earnings Yield | -236.99% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 0.25:1.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.25:1 |
Scores
Zepp Health has an Altman Z-Score of 0.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.22 |
| Piotroski F-Score | 2 |